Related references
Note: Only part of the references are listed.Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles
Simon Y. Graeber et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations
Adam J. Kimple et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2022)
The management of cystic fibrosis chronic rhinosinusitis: An evidenced-based review with recommendations
Daniel B. Spielman et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2022)
Association of Quality of Life Measures and Otolaryngologic Care in Cystic Fibrosis Patients
Stephen Leong et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2022)
Chronic rhinosinusitis in cystic fibrosis: a review of therapeutic options
Joanna Krajewska et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2022)
Olfactory dysfunction in cystic fibrosis: Impact of CFTR modulator therapy
Daniel M. Beswick et al.
JOURNAL OF CYSTIC FIBROSIS (2022)
Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaf tor/tezacaf tor/ivacaf tor therapy in adults with cystic fibrosis
Lena Wucherpfennig et al.
JOURNAL OF CYSTIC FIBROSIS (2022)
Elexacaftor-Tezacaftor-Ivacaftor improve Gastro-Oesophageal reflux and Sinonasal symptoms in advanced cystic fibrosis
Sufyan Shakir et al.
JOURNAL OF CYSTIC FIBROSIS (2022)
Medical interventions for chronic rhinosinusitis in cystic fibrosis
Tulasi Kota Karanth et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2022)
Impact of Cystic Fibrosis Transmembrane Conductance Regulator Therapy on Chronic Rhinosinusitis and Health Status Deep Learning CT Analysis and Patient-reported Outcomes
Daniel M. Beswick et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2022)
Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis
Emily DiMango et al.
JOURNAL OF CYSTIC FIBROSIS (2021)
Impact of novel CFTR modulator on sinonasal quality of life in adult patients with cystic fibrosis
Jennifer E. Douglas et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2021)
Assessment of health-related quality-of-life in patients with chronic Rhinosinusitis - Validation of the German Sino-Nasal Outcome Test-22 (German-SNOT-22)
D. Riedl et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2021)
The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights
D. Dejaco et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2019)
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
Harry G. M. Heijerman et al.
LANCET (2019)
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
P. G. Middleton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Ivacaftor improves rhinologic, psychologic, and sleep-related quality of life in G551D cystic fibrosis patients
Justin McCormick et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2019)
VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
Dominic Keating et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Ivacaftor improves appearance of sinus disease on computerised tomography in cystic fibrosis patients with G551D mutation
S. I. Sheikh et al.
CLINICAL OTOLARYNGOLOGY (2015)
Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype deltaF508/S1215N
C. L. Vreede et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
C. E. Wainwright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Improvement of Sinus Disease in Cystic Fibrosis with Ivacaftor Therapy
Don Hayes et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Upper and lower airway cultures in children with cystic fibrosis: Do not neglect the upper airways
Hilde J. C. Bonestroo et al.
JOURNAL OF CYSTIC FIBROSIS (2010)
Psychometric validity of the 22-item Sinonasal Outcome Test
C. Hopkins et al.
CLINICAL OTOLARYNGOLOGY (2009)
Upper airway . 2: Bronchiectasis, cystic fibrosis and sinusitis
M. R. Loebinger et al.
THORAX (2009)